Results
|
41.
|
|
|
42.
|
|
|
43.
|
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel. [electronic resource] by
- Yu, D C
- Chen, Y
- Dilley, J
- Li, Y
- Embry, M
- Zhang, H
- Nguyen, N
- Amin, P
- Oh, J
- Henderson, D R
Producer: 20010222
In:
Cancer research vol. 61
Availability: No items available.
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. [electronic resource] by
- Chen, Y
- DeWeese, T
- Dilley, J
- Zhang, Y
- Li, Y
- Ramesh, N
- Lee, J
- Pennathur-Das, R
- Radzyminski, J
- Wypych, J
- Brignetti, D
- Scott, S
- Stephens, J
- Karpf, D B
- Henderson, D R
- Yu, D C
Producer: 20010802
In:
Cancer research vol. 61
Availability: No items available.
|
|
48.
|
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. [electronic resource] by
- DeWeese, T L
- van der Poel, H
- Li, S
- Mikhak, B
- Drew, R
- Goemann, M
- Hamper, U
- DeJong, R
- Detorie, N
- Rodriguez, R
- Haulk, T
- DeMarzo, A M
- Piantadosi, S
- Yu, D C
- Chen, Y
- Henderson, D R
- Carducci, M A
- Nelson, W G
- Simons, J W
Producer: 20011204
In:
Cancer research vol. 61
Availability: No items available.
|